Overall, these findings reveal a more critical role for Siah2, rather than Keap1, as a molecular regulator of hypoglycemia-induced Nrf2 degradation and BBB endothelial dysfunction. The gene discussed is NFE2L2; the disease is endothelial dysfunction.